This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Health Care Industry Access Initiative Summit 2013 Slated For Next Week

WASHINGTON, Feb. 6, 2013 /PRNewswire/ -- The issue of health care access has never been more important. To develop industry-focused, innovative solutions to the challenges of creating access, the Health Care Industry Access Initiative, a non-profit organization dedicated to promoting collaborative action across the health care industry to improve health care access, will host Summit 2013: Beyond Health Reform to Health Care Access: Solving Access Challenges to Achieve Success in Health Reform. The Summit will be held Feb. 13-15, 2013, at the FHI 360 Convention Center in Washington, D.C.

Experts will address a range of topics, including fostering consumer engagement in health insurance exchanges (now re-dubbed "marketplaces"); how health care organizations are using social media to connect with consumers; the return of the house call; and the latest innovations in care transitions.

"Ensuring individuals have access to the coverage and care they need is a thornier problem than we could have imagined just a few years ago. If simply 'building it' were sufficient, millions more Americans would have coverage and access to primary care," said Carrie Valiant, founder and president of the Health Care Industry Access Initiative. She is a Member of the Firm in Epstein Becker Green's Health Care and Life Sciences practice, in Washington, D.C. "At this summit, we are bringing together some of the sharpest minds in the country to discuss this and other pressing challenges around access. I am confident we will all leave with a better understanding of what we must do to move the Triple Aim from aspiration to reality."

Paul Grundy, MD, MPH, IBM's global director of healthcare transformation and president of the Patient-Centered Primary Care Collaborative (PCPCC), will deliver the keynote address Thursday morning: "How Patient-Centered Medical Homes Can Transform Patient Access to Healthcare." Grundy champions the notion that patient-centered medical homes (PCMH) can provide a foundation for a high-performing health care system. His work has been widely reported in leading magazines, journals, and broadcast outlets. In 2012, he was elected to the Institute of Medicine.

Wednesday's dinner speaker, Beth Ann Swan, PhD, CRNP, FAAN, dean, Jefferson School of Nursing, will share the challenges she faced as a health professional and caregiver, while navigating the health care system on behalf of her husband. The account was recently published in Health Affairs.

Access to care is the most basic step to achieving the Institute for Healthcare Improvement's Triple Aim—improve the health of the population; enhance the patient experience of care; and reduce, or at least control, the per capita cost of care. Health care reform – or more accurately, its transformation – depends on reaching the consumer: People must sign up for coverage, and then access needed care. But offering – or even mandating – coverage is not enough. Many individuals fail to sign up for programs for which they are eligible, even when those programs are free. More troubling, most uninsured people lack relationships with primary care physicians – the entry point for obtaining cost-effective health care services.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,246.73 +114.03 0.63%
S&P 500 2,112.40 +7.90 0.38%
NASDAQ 4,989.8460 +26.3190 0.53%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs